Romano Brothers & Co’s HCA Healthcare HCA Stock Holding History

Romano Brothers & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$1.73K	–	569
2022 Q4	$1.73K	Buy	+7	New	+$1.57K	﹤0.01%	950

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Romano Brothers & Co's HCA Position: Q1 2023 in Review

Romano Brothers & Co sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 7 shares — an estimated $1.73K sold.

Romano Brothers & Co first reported a position in HCA in Q4 2022 and held it in 1 quarter. The position peaked at $1.73K in Q4 2022. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

Romano Brothers & Co reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 7 HCA Healthcare shares in Q1 2023, an estimated $1.73K.
Romano Brothers & Co first reported a position in HCA Healthcare in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's HCA Healthcare position peaked at $1.73K in Q4 2022.
970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.